Drug Trial Radar · NCT03156153
A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
Last checked: Nov 20, 2026Latest source record: Mar 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
May 24, 2017
Primary completion
Jul 8, 2019
Study completion Jul 10, 2019
Sponsor
- Lead sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Shanghai Jiao Tong University School of Medicine
- First posted
- May 17, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 3 years, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators are going to carry out a randomized double-blind placebo-controlled trial to study the efficiency and mechanism of bumetanide on the treatment of children with Autism Spectrum Disorder.
Conditions
- Autism Spectrum Disorder
Interventions
BumetanideDrug
bumetanide tablets, oral intake, 0.5mg, twice daily, respectively at 8 am and 4 pm
PlaceboDrug
placebo tablets, oral intake, 0.5mg, twice daily, respectively at 8 am and 4 pm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Childhood Autism Rating Scale(CARS)Time frame: Day 0 and Day 90
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xinhua Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.